We are here to assist you.
Health Advisor
+91-8877772277Available 7 days a week
10:00 AM – 6:00 PM to support you with urgent concerns and guide you toward the right care.
A detailed guide on Casodex (bicalutamide) dosage for prostate cancer, including how to take it, missed doses, overdose information, and when to consult a doctor.

Prostate cancer is a significant health concern for many men, and treatment often involves a combination of therapies. Casodex, known generically as bicalutamide, is a crucial medication used in the management of advanced or metastatic prostate cancer. It belongs to a class of drugs called anti-androgens, which work by blocking the effects of male hormones (androgens) that can fuel prostate cancer growth. This blog post provides a detailed look at the dosage of Casodex, how it's administered, and important considerations for patients in India.
Casodex (bicalutamide) is a prescription oral tablet. Its primary function is to act as a hormone therapy for prostate cancer. Androgens, such as testosterone, can stimulate the growth of prostate cancer cells. Casodex works by preventing these androgens from binding to cancer cells, thereby slowing down or stopping the cancer's progression. It is often prescribed in conjunction with other treatments, such as a luteinizing hormone-releasing hormone (LHRH) agonist, to provide a more comprehensive approach to managing the disease.
The standard strength for Casodex is 50 milligrams (mg). The typical dosage prescribed for adults diagnosed with metastatic prostate cancer is 50 mg taken once daily. It is crucial to adhere strictly to the dosage prescribed by your doctor. Self-adjusting the dose can have serious consequences.
Casodex is administered as an oral tablet. Here are some guidelines on how to take it:
Missing a dose of Casodex can happen. If you realize you've missed a dose:
To help remember your medication, consider using a medication reminder app on your phone or setting a daily alarm.
It is vital not to exceed the prescribed dosage of Casodex. Taking more medication than recommended can lead to harmful effects. If you suspect you have taken too much Casodex:
The recommended maximum dose of Casodex is 50 mg once per day. While higher doses (e.g., 150 mg per day) were studied in the past for recurrent prostate cancer, these are not currently approved dosages and other treatments are generally considered more effective.
Casodex can be prescribed for long-term treatment if your doctor determines it is safe and effective for your specific condition. If you have any questions about the duration of your treatment, discuss them openly with your healthcare provider.
Information regarding the expiration date, proper storage conditions, and safe disposal of Casodex should be obtained from your doctor or pharmacist. They can provide guidance tailored to your medication and local regulations.
For individuals who may need assistance with medication management, some pharmacies offer accessible features. These can include:
Inquire with your pharmacist about these or other available accessibility services.
It is essential to maintain regular contact with your doctor while undergoing Casodex treatment. You should consult your doctor if you:
Disclaimer: This information is intended for educational purposes and should not be considered medical advice. Always consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
Learn about potential side effects of CML treatments like TKIs, interferon, chemotherapy, and stem cell transplants. Understand what to expect and how to communicate with your doctor for effective management.
April 1, 2026

Discover essential support resources, financial aid options, and community connections for individuals navigating life with Chronic Myeloid Leukemia (CML). Find practical advice and empathetic guidance.
April 1, 2026
Explore targeted therapy for multiple myeloma. Learn how these precision treatments work, their types, potential side effects, and how they're used alongside other therapies to manage this blood cancer.
April 1, 2026